Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Notes Payables (2020)

Historic Notes Payables for SOPHiA GENETICS (SOPH) over the last 1 years, with Q4 2020 value amounting to $2.9 million.

  • SOPHiA GENETICS's Notes Payables changed N/A to $2.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was $2.9 million, marking a year-over-year change of. This contributed to the annual value of $2.9 million for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q4 2020, SOPHiA GENETICS's Notes Payables is $2.9 million.
  • In the past 5 years, SOPHiA GENETICS's Notes Payables ranged from a high of $2.9 million in Q4 2020 and a low of $2.9 million during Q4 2020